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ABSTRACT 
Fear of Pain and Dental Care-Related Fear: Associations with the MC1R Gene 
 
Cameron L. Randall, M.S. 
 
 
Fear of pain is experienced in acute and chronic pain populations, as well as generally, and 
impacts numerous aspects of the pain experience, including pain intensity, pain-related disability, 
and pain behavior (e.g., avoidance). A related but separate construct, dental care-related fear, 
also is experienced in the general population, and impacts dental treatment-seeking behavior and 
oral and systemic health. Very minimal work has addressed the role of genetics in the etiologies 
of fear of pain and dental care-related fear. Limited available data suggest that variants of the 
melanocortin-1 receptor (MC1R) gene may predict greater levels of dental care-related fear. The 
MC1R gene also may be important in the etiology of fear of pain. This study aimed to confirm 
that MC1R variant status predicts dental care-related fear and to determine, for the first time, 
whether MC1R variant status predicts general fear of pain. Participants were 817 Caucasian 
adults (62.5% female, M age = 34.7 years, SD = 8.7) who were part of a larger, cross-sectional 
project that sought to identify determinants of oral diseases at the community-, family-, and 
individual levels (Center for Oral Health Research in Appalachia, cohort 1; COHRA1). 
Participants were genotyped for SNPs on MC1R and completed self-report measures of fear of 
pain and dental care-related fear. Variation on MC1R predicted higher levels of dental care-
related fear and fear of pain. Importantly, fear of pain mediated the relation between MC1R 
variant status and dental care-related fear, B = 1.60, 95% CI [0.281, 3.056]. MC1R variants may 
influence orofacial pain and, in turn, predispose individuals to develop fears about pain. Such 
fears influence the pain experience and associated pain behaviors, as well as fears about dental 
treatment. This study provides support for small genetic contributions to the 
development/maintenance of fear of pain and dental care-related fear. These findings suggest 
directions for future research to identify potential targets for intervention in the treatment of fear 
of pain and dental care-related fear.  
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FEAR OF PAIN, DENTAL FEAR, AND MC1R  1  
Fear of Pain and Dental Care-Related Fear: Associations with the MC1R Gene 
 Fear of pain and dental care-related fear1 both are well-studied phenomena, each 
ubiquitous and with far-reaching and important effects on health behavior. Fears about pain and 
injury are the third most commonly reported of all fears (Oosterink, de Jongh, & Hoogstraten, 
2009), and fear of pain is associated with pain-related disability, pain intensity, and pain 
behavior, among other aspects of the pain experience, across medical and general populations 
(e.g., Buer & Linton, 2002; Crombez, Vlaeyen, Heuts, & Lysens, 1999; McCracken, Gross, 
Aikens, & Carnkike, 1996). Fears about dental treatment, related to but distinct from fear of pain, 
is similarly prevalent; in the United States of America, close to half of the population reports 
experiencing at least moderate levels of dental care-related fear (Dionne, Gordon, McCullagh, & 
Phero, 1998), with between 5 and 10 percent of adults reporting avoidance of necessary dental 
treatment as a result of this fear (Milgrom, Weinstein, & Heaton, 2009). Avoidance behaviors 
associated with both fear of pain and dental care-related fear detrimentally impact physical and 
psychological wellbeing (e.g., Crofts-Barnes, Brough, Beddis, & Girdler, 2010; Schuller, 
Willumsen, & Holst, 2003; Verbunt, Seelen, & Vlaeyen, 2004). Critical to reducing the burden 
of these phenomena is a more complete conceptualization of their etiologies. Minimal extant 
literature addresses the role of genetics in the etiology of dental care-related fear and, at this 
time, only one known study addresses the influence of genetic factors on the development and 
maintenance of general fear of pain. Knowledge in this area has the potential to significantly 
impact these public health concerns. 
Role of Genetics in Fear of Pain and Dental Care-Related Fear 
  Biological factors likely play a role in the development and maintenance of fear in some 
individuals. Contemporary psychology, including behavioral neuroscience, acknowledges the 
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importance of biological and genetic factors as predisposing individuals to be more or less likely 
to develop psychopathology, including problems such as dental care-related fear (McNeil & 
Randall, 2014). Genetic differences may influence across several domains (e.g., anxiety 
sensitivity, fear conditioning, cognitive vulnerability, pain sensitivity) whether and how an 
individual acquires fears about pain and/or dental treatment. To be sure, the role of genetics in 
fear and anxiety is becoming better understood, as much research has focused on the topic.  
 Over the last several decades, genetics has received much attention in the 
psychopathology literature (Malouff, Rooke, & Schutte, 2008). Even before then, researchers 
aimed to understand how genetic factors affect human behavior, more widely (Malouff et al., 
2008). The earliest work of this type in the area of anxiety involved family studies, which 
provided evidence that anxiety disorders specifically, and probably fear and anxiety more 
generally, have a high degree of familial aggregation (Smoller, Block, & Young, 2009). Later, 
twin studies offered fairly definitive evidence that anxiety disorders are heritable (Hettema, 
Neale, & Kendler, 2001; Smoller et al., 2009) and demonstrated that, while important, 
environment does not completely account for observed familial aggregation. Across anxiety 
disorders, the degree of heritability appears to be relatively high, with estimates ranging from 20-
51% (e.g., Distel et al., 2008; Maron, Hettema, & Shlik, 2008; Smoller et al., 2009; Timpano, 
Hasler, Riccardi, Murphy, & Schmidt, 2009). Work in behavioral genetics (e.g., Farmer, Eley, & 
McGuffin, 2005; Jang & Shikishima, 2009) has targeted the genetic underpinnings of anxiety 
disorders, as well as gene-environment interactions, and several genes and associated pathways 
have been implicated as important in the pathogenesis of disorders related to fear and anxiety 
(e.g., Hudson & Pope, 2007; van Eekelen et al., 2011). 
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 Genetic variation certainly is responsible, in part, for individual differences in 
problematic fear and anxiety, generally. Genetic factors can serve as a diathesis for high levels of 
fear via several routes (McNeil & Randall, 2014). With regard to fear of pain, the only known 
study to address genetic factors suggests that there is a moderate degree of heritability (i.e., 34% 
in a family-based cohort study of adolescents and adults; Randall et al., 2016b). A similar degree 
of heritability was observed for dental care-related fear in the same sample (30%), and the 
genetic correlation between dental care-related fear and fear of pain was substantial (rhoG = 
0.67), providing biological evidence that the two are related but distinct constructs (Randall et 
al., 2016b). The first known study of the heritability of dental care-related fear utilized twin 
study methodology in a sample of adolescents and estimated heritability to be moderately high 
for both boys and girls (30-47%; Ray et al., 2010). In another twin study of dental care-related 
fear, moderate heritability (41%) also was found in a sample comprised of individuals aged 23-
35 years (Vassend et al., 2011). In that study, there was a high degree of genetic correlation 
between dental care-related fear and the personality trait neuroticism, leading the authors to 
suggest that the two phenotypes are distinct but may share similar etiologies. A genetic 
predisposition for higher neuroticism may have a cascade effect on dental care-related fear. 
Together, these limited data provide evidence that genetic factors may be especially important in 
understanding the observed intergenerational transmission of dental care-related fear (e.g., Lara, 
Crego, & Romero-Maroto, 2012; McNeil, Randall, Crout, Weyant, Marazita, 2014). 
 Extending the conclusions drawn by the results of these heritability studies, candidate 
gene analysis recently has been applied to research on dental care-related fear. Long has been 
clinical lore that patients with red hair are more sensitive to pain, less likely to experience 
analgesia following lidocaine injections, and more likely to be fearful or anxious about 
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medical/dental treatment than their blonde-, brown-, or black-haired counterparts (e.g., Flaherty, 
2010; Thompson, 2011). Such anecdotes seem to interest the general population, as discussion of 
the topic has appeared in high-profile lay press publications like National Geographic (Conant, 
2014) and TIME (Melnick, 2010), perpetuating the story. Given this lore, and that variants in the 
melanocortin-1 receptor (MC1R) gene cause redheadedness, Binkely and colleagues (2009) 
studied the role of the MC1R gene in dental care-related fear and fear of dental pain. Working 
under the assumption that resistance to local anesthesia may result in more painful dental 
experiences, which may condition fears of dental pain and dental treatment, the researchers 
tested whether having MC1R gene variants was associated with fear of dental pain, dental care-
related fear, and avoidance of dental care. Results suggested that MC1R gene variant status (i.e., 
having one or more gene variants versus no variants) predicts greater fear of dental pain and 
dental care-related fear (R2 = .18), as well as a two-fold increase in the likelihood of avoiding 
dental care. This single study suggests that the MC1R gene may be particularly important for 
understanding individual differences in dental care-related fear. Given the well-evidenced 
relation between dental care-related fear and fear of pain, more generally, results from the 
Binkely et al. (2009) study provide reason to study the potential association between the MC1R 
gene and general fear of pain and provide a model for completing candidate gene analysis in the 
dental care-related fear and fear of pain arenas. 
Melanocortin-1 Receptor Gene, Pain, and Anxiety 
 Melanocortins are hormones derived from the proopiomelanocortin gene, and refer to 
adrenocorticotropin (ACTH) and α-, β-, and γ-melanocyte-stimulating hormones (Chaki & 
Okuyama, 2005). These hormones have been implicated in various physiological functions, such 
as memory and learning (de Wied & Jolles, 1982), analgesia (Vrinten, Adan, Groen, & Gispen, 
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2001; Vrinten, Gispen, Groen, & Adan, 2000), stress responses (Adan et al., 1999; von Frijtag, 
Croiset, Gispen, Adan, & Wiegant, 1998), and inflammation (Ceriani, Mcalus, Catania, & 
Lipton, 1994), among others (see Chaki & Okuyama, 2005). Five receptors are activated by 
melanocortins (MC1R-MC5R), each coded for by different genes, and contributing to different 
physiological functions (Chaki & Okuyama, 2005). MC1R plays a major role in skin 
pigmentation, and so variations in the MC1R gene, which is on chromosome 16, are associated 
with skin fairness and red hair color (Raimondi et al., 2008). It has been suggested that the 
MC1R gene also plays a role in other phenotypes. For instance, across people of all 
pigmentation, the expressed gene has been found in brain tissue of the pathways responsible for 
the experience and processing of pain, anxiety, and fear (Chaki & Okuyama, 2005; Xia, 
Wikberg, & Chhajlani, 1995), fitting with evidence that suggests that the related MC4R gene and 
the melanocortinergic pathway are important in anxiety behavior (Chaki & Okuyama, 2005; Liu 
et al., 2007). 
 Generally speaking, genetic variation seems to account for small to moderate amounts of 
variance in pain perception, with various pathways and mechanisms proposed (see Shi, Cleeland, 
Klepstad, Miaskowski, & Pedersen, 2010; Vasileiou, Giaginis, Klonaris, & Theocharis, 2009). 
Moreover, differences in pain perception across pain types or modalities, within the same 
individual, appear to involve a genetic component (Nielsen et al., 2008). For example, in 
addition to the MC1R gene (e.g., Mogil et al., 2005), several genes have been identified as 
potentially important in the pain experience, such as the SCN9A (e.g., Drenth & Waxman, 2007), 
OPRM1 (e.g., Fillingim et al., 2005), and COMT genes (e.g., Diatchenko et al., 2005; Zubieta et 
al., 2003). Animal studies provide strong support that the melanocortin system plays a role in 
nociception (e.g., Beltramo et al., 2003). Specifically, MC1R, and thus the MC1R gene, appear to 
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play a significant role in acute pain perception, a role that may be sex-specific (e.g., female, but 
not male, mice lacking MC1R demonstrate increased tolerance to thermal pain; Delaney, 
Keighren, Fleetwood-Walker, & Jackson, 2010). Research with humans has yielded similar 
results as the translational work with animals; MC1R genotype affects pain sensitivity, including 
dental pain sensitivity (Liem, Joiner, Tsueda, & Sessler, 2005; Mogil et al., 2005), with several 
single nucleotide polymorphisms (SNPs) identified as particularly important (García-Borrón, 
Sánchez-Laorden, & Jiménez-Cervantes, 2005). Related to pain perception, MC1R gene variants 
are associated with reduced efficacy of and increased need for general and local (including 
dental) anesthesia (e.g., Liem et al., 2004; Liem et al., 2005; Myles, Buchanan, & Bain, 2012). 
MC1R expression and presence of MC1R has been identified in periaqueductal gray 
matter cells (Xia et al., 1995), the primary control center for descending pain modulation. There 
are no known relevant data indicating the mechanism by which MC1R is associated with pain 
perception nor the downstream effects of MC1R variation on protein function as related to pain 
experience. However, it has been suggested that central MC1R involvement and/or peripheral 
dysfunction activates central MC4Rs to impact pain sensitivity (Andresen, Lunden, Drewes, & 
Arendt-Nielsen, 2011), which may partly explain why MC1R variation is correlated with 
hypersensitivity to pain. 
These data lend themselves to the development of two predictions regarding the relation 
between MC1R gene variant status and dental care-related fear: (1) MC1R gene variants produce 
heightened pain sensitivity, which may result in more readily conditioned fear of pain and dental 
care-related fear, and/or (2) reduced anesthesia efficacy associated with MC1R gene variants 
results in more painful dental procedures, which may lead to the conditioning of fear of pain and 
dental care-related fear (Binkely et al., 2009). While such explanatory mechanisms are likely 
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(and testable), it may also be the case that variants in the MC1R gene impact anxiety generally, 
including fears and anxieties about pain and dental treatment. The melanocortin pathway (and 
notably MC4R) is involved in emotional stress-induced anxiety and activation of the 
hypothalamo-pituitary-adrenal axis (Cragnolini, Schiöth, & Scimonelli, 2005; Liu, Garza, Li, & 
Lu, 2013), and anxiety and depression more broadly (Chaki & Okuyama, 2005). Thus, the 
related MC1R (and the MC1R gene) may be important in understanding anxieties and fears such 
as fear of pain and dental care-related fear. Given that the MC1R and MC4R genes are expressed 
in similar regions of the brain (Xia et al., 1995), more research on the less-studied MC1R gene is 
necessary in order to determine its potential role in both general and specific fears/anxieties. 
Understanding Fear of Pain: A Biopsychosocial Perspective 
 Pain has been described as “an unpleasant sensory and emotional experience associated 
with actual or potential tissue damage, or described in terms of such damage” (International 
Association for the Study of Pain Task Force on Taxonomy, 1994, p. 211). Indeed, pain is 
complex, and biological predisposition and learning history shape idiosyncratic pain experiences 
(International Association for the Study of Pain Task Force on Taxonomy, 1994). Under a 
multidimensional and biopsychosocial framework, it has been suggested that several factors 
influence an individual’s experience of pain. Specifically, Turk and Flor (1999, p. 20) have 
asserted that “predispositional factors and current biological factors may initiate, maintain, and 
modulate physical perpetuations; predispositional and current psychological factors influence the 
appraisal and perception of internal physiological signs; and social factors shape the behavioral 
responses of patients to the perceptions of their physical perturbations.” 
Given the affective nature of pain, the experience involves a significant psychological 
component. A large body of research suggests that emotions, especially fear and anxiety, play an 
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important role in the experience of pain (e.g., Geisser et al., 1994, McCracken, Zayfert, & Gross, 
1992). For example, in several contexts, fear is associated with reports of higher levels of 
experienced pain (e.g., Fillingim, 2000; Fillingim, Keefe, Light, Booker, & Maixner, 1996; 
Fillingim, King, Ribeiro-Dasilva, Rahim-Williams, & Riley, 2009; van Wijk, de Jongh,  
Lindeboom, 2010; van Wijk & Hoogstraten, 2009). Similarly, perceived control is predictive of 
pain tolerance and threshold and may reduce autonomic arousal in instances of acute pain 
stimulation (Feldner & Hekmat, 2001; Geer, Davison, & Gatchel, 1970). Given the clear relation 
between fear/anxiety and pain perception, several researchers and theoreticians have suggested 
that fear of pain, specifically, may be a particularly important variable in the experience of pain, 
and notably in regard to avoidance and other pain behaviors. 
 Fear of pain involves irrational dread or apprehension about nociception resulting from 
any of a variety of sources (e.g., breaking a bone, falling, receiving an injection, chronic 
musculoskeletal pain; see Asmundson, Vlayen, & Crombez, 2004). A model put forth by 
Asmundson, Norton, and Vlaeyen (2004) proposes that the fear is directed not just at the pain-
inducing stimuli, but also experiences or behaviors that an individual previously has associated 
with pain. As with fears, generally, fear of pain presents as responses in three domains – 
physiological, behavioral, and cognitive – with idiosyncratic presentation across individuals, and 
interaction between the responses (Asmundson et al., 2004; Lang, 1968). In other words, fear of 
pain, as manifested across the three response systems, influences and is influenced by the 
perception of pain, physiologic reactivity to pain sensations, pain behavior (e.g., avoidance, 
reassurance seeking, help seeking), and cognitions about the pain (e.g., catastrophizing, 
misappraisals, misattributions). Several models of the pain experience, the pain-avoidance 
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relation, and fear of pain outline the connections between these variables (see Asmundson et al., 
2004). 
Impact of Fear of Pain 
 Across clinical and non-clinical populations, and with regard to both chronic and acute 
pain, fear of pain can have a profound impact on individual behavior. For example, it has been 
suggested that fear of pain operates to maintain chronic pain over time; even after a muscle or 
tissue injury has healed, avoidance behavior is perpetuated by fear of pain and results in 
deconditioning (e.g., muscle tissue loss, weight gain, decreased strength; Asmundson, Vlaeyen, 
& Crombez, 2004). In a pain-avoidance cycle, avoidance behavior is reinforced when this 
deconditioning leads to further pain and negative experiences (Asmundson et al., 2004). Thus, a 
vicious cycle is set up such that fear of pain perpetuates and is exacerbated by the experience of 
chronic pain. 
Fear of pain has been well studied in chronic pain populations (e.g., Hursey & Jacks, 
1992; Lee, Chiu, & Lam, 2007; Turk, Robinson, & Burwinkel, 2004; Vlaeyen, de Jongh, Geilen, 
Heuts, & van Breuklen, 2001). Fear of pain is associated with or predicts several negative 
aspects of the chronic pain experience. For example, fear of pain is positively associated with 
pain intensity across several chronic pain populations (e.g., low back pain, headache; 
Asmundson, Norton, & Veloso, 1999; Vlaeyen et al., 2001). Fears about pain also are highly 
associated with reduction in physical activity and normal movement in people suffering from 
chronic low back pain (Verbunt, Seelen, & Vlaeyen, 2004). Additionally, fear of pain is the 
strongest predictor of disability and poor behavioral performance in individuals experiencing 
chronic pain (Crombez et al., 1999). Moreover, specific fears about pain versus more general 
fears or anxieties are associated with maladaptive pain behaviors – notably avoidance, 
 10 
complaining, and help-seeking – in individuals with chronic pain (McCracken et al., 1996).   
Studies assessing cognitive performance and attention bias in chronic pain samples have 
suggested that information processing systems may be significantly influenced by fear of pain, 
such that hypervigilance to pain-related stimuli is borne out of fear of pain and maintains pain 
behaviors, notably avoidance (Asmundson, Kuperos, & Norton, 1997; van Damme, Crombez, 
Eccleston, & Roelofs, 2004). In individuals with chronic pain, fear of pain also may be a critical 
part of the mechanism responsible for the relation between anxiety sensitivity and the pain 
experience (Ocaňez, McHugh, & Otto, 2010; Zvolensky, Goodie, McNeil, Sperry, & Sorrell, 
2001). 
The role of fear of pain in non-clinical samples and in the experience of acute pain has 
been studied less than in chronic pain samples; however, extant data suggest that fear of pain 
exists in the general population (Buer & Linton, 2002) and impacts the perception of acute pain 
across experimental and naturalistic contexts. For instance, self-reported pain intensity is 
positively associated with fear of pain in cases in which nociception is experimentally induced in 
healthy participants using ischemic, electrical, or thermal pain tests (George, Dannecker, & 
Robinson, 2006; Roelofs, Peters, Deutz, Spijker, Vlaeyen, 2005). Using a cold pressor paradigm 
to experimentally induce pain sensations in a non-clinical sample, fear of pain has been found to 
predict self-reported pain intensity over and above catastrophizing (Hirsh, George, Binlosky, & 
Robinson, 2008). Early work suggests that the ventral lateral frontal region, responsible for 
response regulation, and the anterior and posterior cingulate regions, associated with monitoring 
and evaluation of affective responses, may be the parts of the brain that are particularly important 
in the relation between fear of pain and acute pain perception (Ochsner et al., 2006). Fear of pain 
has been found to predict not only self-reported pain intensity, but also degree of disability, using 
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an experimental paradigm that involved exercise-induced musculoskeletal injury (Parr et al., 
2012). Likewise, in a sample of individuals experiencing acute low back pain, fear of pain was 
negatively associated with change in disability, even after controlling for pain intensity (George, 
Fritz, & McNeil, 2006). Together, the evidence from studies utilizing clinical and non-clinical 
samples, across acute and chronic pain experience, suggests that fear of pain undoubtedly plays a 
critical role in the perception of nociception and in an individual’s behavioral response to pain. 
Fear of Pain and its Relation to Dental Pain 
 Though the literature is limited, experimental evidence suggests that sensitivity to one 
type of pain is not necessarily a good indication of sensitivity to other types of pain. For 
example, individuals often demonstrate varying degrees of pain tolerance and threshold across 
different types of experimentally-induced pain (i.e., thermal versus pressure versus electrical 
stimulation; Janal, Glusman, Kuhl, & Clark, 1994). Complicating our understanding of 
nociception even further, it is clear that individuals demonstrate varying pain sensitivity across 
organ systems and regions of the body, with psychological variables playing a role. Notably, 
dental pain sensitivity appears to be related to, but distinct from, pain sensitivity in other parts of 
the body. For instance, Kelpac, Dowling, and Hauge (1982) found significant differences in 
dental pain tolerance, but not non-dental pain tolerance, between individuals who were and were 
not fearful of dental treatment. 
Indeed, the experience of oral/dental pain is unique, compared to bodily pain in other 
areas, and even is described differently by individuals who are in pain (e.g., Grushka & Sessle, 
1984; McNeil, Vargovich, Sorrell, & Vowles, 2014). Several factors may be important for the 
difference between dental and other pain, such as the way in which teeth are innervated 
compared to innervation of other parts of the body (Fried, Sessle, & Devor, 2001; Hildebrand, 
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Fried, Tuisku, & Johansson, 1995; McNeil et al., 2014). Though dental professionals concern 
themselves with pain conditions of the hard and soft tissues of the head, face, neck, and intraoral 
cavity, collectively understood as orofacial pain (de Leeuw, 2008), dental pain often is 
conceptualized by others as toothache, injury to the teeth or jaw, or pain related to dental 
procedures (e.g., restoration, extraction, endodontic therapy; McNeil et al., 2014). Dental pain 
commonly is experienced, manifests in a variety of ways, and can be influenced by numerous 
biological, psychological, social, and environmental factors (McNeil et al., 2014). 
Few studies have addressed the relation between fear of pain and perceived orofacial or 
dental pain; however, available data suggest that, like other types of pain, fear of pain impacts 
the experience of orofacial pain. The earliest work in the area provided evidence that orofacial 
pain patients, compared to matched healthy controls, report greater levels of general fear of pain, 
especially fear of severe pain (McNeil et al., 2001). Fear of dental pain, specifically, has been 
positively associated with experiencing greater duration and intensity of pain resulting from an 
intraoral injection (van Wijk & Hoogstraten, 2009). Not surprisingly, individuals who have 
experienced dental pain overestimate fear of specific dental pains (van Wijk & Hoogstraten, 
2005). Though additional work is necessary to more definitively demonstrate a link between fear 
of pain and dental pain specifically, existing literature indicates that fear of dental pain and 
experienced orofacial and/or dental pain are related in a bidirectional or cyclical manner. 
Fear of Pain is a Critical Component of Dental Care-Related Fear 
 Given the potential for pain in dental treatment, several researchers have focused 
attention on the relations among orofacial pain, fears about pain, and fears about dental 
treatment, more generally. To be certain, a relatively large body of evidence provides support for 
a strong association between fear of pain and dental care-related fear. McNeil and Berryman 
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(1989) published the first known data suggesting that fear of pain is a key component of dental 
care-related fear. This finding has been replicated across several clinical and community samples 
and across age groups (e.g., McNeil et al., 2001; McNeil et al., 2011; McNeil et al., 2013; 
Randall, McNeil, & Stuchell, 2012; Randall, et al., 2016b). Relatedly, fear of dental pain, 
specifically, has been associated with dental care-related fear in several studies (e.g., Binkley et 
al., 2009; van Wijk & Hoogstraten, 2003). It appears that fearing nociception associated with 
dental treatment may predispose or reinforce in patients dental care-related fear (McNeil & 
Randall, 2014). 
Understanding Dental Care-Related Fear and Anxiety: Conceptual and Etiological Issues 
  Dental care-related fear and anxiety are distinct but related phenomena, with complex 
etiologies, that are ubiquitous and impact health behavior. As a result of their associations with 
oral, systemic, and psychological health, and their widespread prevalence, dental care-related 
fear and anxiety represent public health concerns that warrant scientific and clinical attention. 
Though complete conceptualizations of these phenomena still are being constructed, much 
already is understood about the development, maintenance, and implications of them. To begin, 
dental care-related fear and anxiety, just as with fears and anxieties related to other stimuli, are 
separate phenomena, even if there is significant overlap (McNeil, Vrana, Melamed, Cuthbert, & 
Lang, 1992; Poulton, Waldie, Thomson, & Locker, 2001). Typically, dental care-related fear 
describes an individual’s physiological, behavioral, and cognitive responses to dental stimuli, 
almost always occurring in the immediate presence of those stimuli (Craske, 2003; Lang, 1968). 
Specifically, dental care-related fear often is characterized by physiological responsivity, 
avoidance behavior, and feelings and verbal report of apprehension or tension, with the 
physiological component particularly strong (Craske, 2003; McNeil & Randall, 2014). Dental 
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care-related anxiety, on the other hand, describes an emotional response to stimuli related to 
dental treatment that often occurs prior to and in anticipation of encountering the stimuli. 
Cognitions, namely negative thoughts and worries, are a key feature of anxiety, often playing 
much more of a role than in the fear response (Craske, 2003; McNeil & Randall, 2014). Most 
“nervous” dental patients experience both dental care-related fear and anxiety. Available 
psychometrically sound measures of dental care-related fear and anxiety do not make a 
distinction between the two phenomena; therefore, for the purposes of this study, ‘dental care-
related fear’ will refer to what likely is both dental care-related fear and/or anxiety. 
Though often incorrectly thought of as binary phenomena (i.e., fearful or non-fearful), 
contemporary conceptualizations of dental care-related fear and anxiety consider their experience 
as falling somewhere on a continuum (see McNeil & Randall, 2014). That is, dental care-related 
fear and anxiety are dimensional, with patients experiencing any of a range of levels of fear or 
anxiety, from no fear/anxiety at all to “normal” levels of fear/anxiety to significant or even 
phobic levels of fear/anxiety. At very high or phobic levels, dental care-related fear probably best 
is conceptualized as Specific Phobia, Situational Type (de Jongh et al., 1998; Leutgeb, Schäfer, 
& Schienle, 2011; McNeil & Randall, 2014). The most recent iteration of the Diagnostic and 
Statistical Manual for Mental Disorders (5th ed.; DSM-5; American Psychiatric Association, 
2013) suggests that all instances of dental phobia should be categorized as Blood-Injury-Illness 
(BII) Phobia; however, given what is known about dental phobia, this categorization is not 
always appropriate and such a diagnostic strategy therefore may be inaccurate (see McNeil & 
Randall, 2014). Of course, in some cases, dental care-related fear can be well understood as a BII 
Phobia or as an injection phobia (McNeil & Randall, 2014). Still, it should be reiterated that 
patients need not experience phobic levels of dental care-related fear in order for the fear to 
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manifest in a noteworthy or impactful manner. Individuals along the continuum of dental care-
related fear have a unique and idiosyncratic experience and presentation of fear, or alternatively, 
comfort, related to dental situations. 
Several mechanisms describing the developing and maintaining factors of dental care-
related fear have been posited. Thus, a number of etiological factors can explain dental care-
related fear, with current conceptualizations combining many of the models (see McNeil & 
Randall, 2014). First, conditioning models suggest that dental care-related fear develops and is 
maintained through classical and operant conditioning paradigms. For example, fear of the dental 
situation may be the result of, and perpetuated by, associations made between dental stimuli 
(e.g., the sound of a drill) and aversive experiences (e.g., pain, lack of control; Davey, 1989; 
Kent, 1985). Likewise, dental care-related fear may develop via positive reinforcement when a 
child displaying fear behavior encounters special attention from the dental professional or a 
parent, or via negative reinforcement, when fear behavior (e.g., squirming, taking frequent 
breaks) provides relief from aversive dental stimuli (McNeil & Randall, 2014). Newer 
conditioning models have highlighted the role of avoidance in maintaining dental care-related 
fear. A vicious cycle of dental care-related fear has been described such that a negative dental 
experience leads to dental care-related fear, which leads to avoidance of dental treatment, and 
then to dental problems, and thus additional aversive dental experiences, completing the cycle by 
perpetuating dental care-related fear (see Armfield, Stewart, & Spencer, 2007). 
Second, social learning theory has been applied to dental care-related fear. These 
conceptualizations of the etiology of fears about dentistry suggest that, through observational or 
vicarious learning mechanisms, dental patients become fearful, even when they never have 
experienced painful or negative dental situations, by learning about the (potentially) aversive 
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nature of dental procedures from family, friends, or the media (McNeil, Randall et al., 2014; 
Melamed & Williamson, 1991; Milgrom et al., 2009). 
Third, cognitive models of the acquisition and maintenance of dental care-related fear 
propose that misperceptions, misattributions, cognitive biases, and negative thinking patterns are 
critical. Data suggest that misappriasing risk and thinking patterns that involve catastrophizing 
are important moderators of dental care-related fear (de Jongh, Muris, ter Horst, van Zuuren, & 
de Wit, 1994). A cognitive vulnerability model describes dental care-related fear as being the 
result, at least in part, of maladaptive thinking style and misperceptions about controllability, 
predictability, dangerousness, and disgustingness (Armfield, 2006; 2010a). Learning history and 
genetic predispositions related to anxiety likely are important in this cognitive vulnerability 
(McNeil & Randall, 2014). 
Fourth, models that include personality traits suggest that the etiology of dental care-
related fear involves stable trait anxiety and/or neuroticism, and some data support such models 
(Thomson, Broadbent, Locker, & Poulton, 2009; Vassend, Roysamb, & Nielsen, 2011). Lastly, 
pain-related factors may be particularly important in understanding the etiology of dental care-
related fear. For instance, heightened pain sensitivity and low pain tolerance/threshold may 
provide a critical vulnerability for dental care-related fear (Bernstein, Kleinknecht, & Alexander, 
1979; Wardle, 1982). Several studies highlight the importance of pain perception in the 
experience of dental care-related fear (e.g., Sandikop, Agrawal, & Patil, 2011; Tickle, Milsom, 
Crawford, & Agrawal, 2012; van Wijk & Makkes, 2008). A comprehensive conceptual model 
describing dental care-related fear, and incorporating each of these important etiological factors, 
has been proposed by McNeil and Randall (2014; see Appendix A). That model includes 
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biological and genetic factors, which also are theoretically important. Given that these factors are 
understudied, they are the subject of this project.  
Impact of Dental Care-Related Fear 
 As noted earlier, dental care-related fear is common, with 45 million adults living in the 
USA reporting at least moderate levels (Dionne et al., 1998), and similar rates reported in other 
parts of the world (e.g., Armfield et al., 2006; Domoto et al., 1988; Klinberg, Berggren, & 
Noren, 1994; Moore, Birn, Kirkegaard, Brodsgaard & Scheutz, 1993). The most recent meta-
analysis on the topic suggests that between 10 and 20% of American adults report a high degree 
of dental care-related fear, a prevalence rate that has remained stable over the last six decades, 
even though dental treatment has seen vast improvements in quality and comfort (Smith & 
Heaton, 2003). Dental phobia, dental care-related fear at the extreme, is the third most prevalent 
phobia (Oosterink et al., 2009). Clearly, dental care-related fear affects a great number of people. 
It should be noted, however, that this fear is not distributed evenly across the population. 
Consistently published is the finding that more women, compared to men, report higher levels of 
dental care-related fear (e.g., Craske, 2003; Doerr Doerr, Lang, Nyquist, & Ronis, 1998; Heft, 
Meng, Bradley, & Lang, 2007; Liddell & Locker, 1997); the reasons for this sex difference are 
not completely known (McNeil & Randall, 2014). Across ages, there is a bimodal distribution of 
dental care-related fear in the population, with young adults and middle-aged adults reporting 
higher levels of fear (Oosterink et al., 2009), and older adults reporting lower levels of fear 
(Armfield, Spencer, & Stewart, 2006; Locker & Liddel, 1991), relative to other age groups. 
Among other demographic variables, lower socioeconomic status appears to be related to greater 
levels of dental care-related fear (Armfield et al., 2006; Doerr et al., 1998). 
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 A defining manifestation of fear is avoidance behavior, and dental care-related fear, not 
surprisingly, leads to (and is exacerbated by) avoidance of both asymptomatic and symptomatic 
dental treatment. Specifically, dental care-related fear is negatively associated with frequency of 
dental check-ups (Doerr et al., 1998), and positively associated with avoidance of dental 
appointment scheduling (Meng, Heft, Bradley, & Lang, 2007) and avoidance of dental treatment 
(Armfield et al., 2007). These associations are demonstrated even when controlling for 
socioeconomic status and treatment accessibility. Not surprisingly, treatment avoidance is 
correlated with poorer oral health (e.g., decayed and missing teeth, fewer functional teeth; 
Schuller et al., 2003). Treatment avoidance has been suggested as serving a mediating role in the 
predictive positive association between dental care-related fear and number of decayed and 
missing teeth, and predictive negative association between fear and number of filled teeth, as 
observed in two large-scale, community-based studies (Armfield, Slade, & Spencer, 2009; 
Randall, McNeil, Wiener et al., 2013). In addition to treatment avoidance, dental care-related 
fear also is negatively associated with oral self-care, such as brushing, flossing, and compliance 
with treatment regimens (Ojima et al., 2005; Riley, Gilbert, & Heft, 2006). Taken together, 
available data provide substantial support that dental care-related fear greatly impacts dental care 
utilization and associated oral health status. 
 Poorer oral health associated with dental care-related fear has been tied to several 
negative psychological outcomes. For example, dental care-related fear and associated oral 
health outcomes are positively correlated with dissatisfaction with one’s mouth (Doerr et al., 
1998). Dental care-related fear also is associated with lower quality of life (Crofts-Barnes et al., 
2010) and lower self-esteem and morale (Locker, 2003). 
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Similarly, a large body of literature has linked poorer oral health with numerous negative 
systemic health outcomes. For instance, untreated dental disease may exacerbate diabetes and 
cardiovascular disease (Williams et al., 2008). Epidemiological and laboratory studies suggest 
that periodontal infections increase the risk for and worsen atherosclerosis and pulmonary 
infections (Scannapieco & Genco, 1999). Likewise, periodontal disease has been linked to 
increased risk for coronary heart disease (Morrison, Ellison, & Taylor, 1999) and 
cerebrovascular disease (Wu et al., 2000). Several mechanisms have been proposed to explain 
the relation between systemic disease and oral infection, such as metastatic spread of infection, 
metastatic injury by circulating toxins, and metastatic inflammation caused by that injury (Li, 
Kolltveit, Tronstad, & Olsen, 2000), and early evidence suggests that the link between dental and 
systemic diseases is causal in nature (Haumschild & Haumschild, 2009; Joshipura, Ritchie, 
Douglass, 2000). Relatedly, untreated dental disease also is associated with worse pregnancy 
outcomes, possibly the result of infection affecting the unborn fetus (e.g., Gaffield, Colley-
Gilbert, Malvitz, & Romaguera, 2001; Offenbacher et al., 1996). Given the far-reaching impact 
of dental care-related fear, and the high prevalence worldwide, dental care-related fear often is 
considered a public health concern (McNeil & Randall, 2014). 
Statement of the Problem and Study Aims 
 Fear of pain and dental care-related fear both are complex phenomena with multifactorial 
etiologies across the population (Asmundson et al., 2004; McNeil & Randall, 2014). As outlined 
earlier, high levels of general fear of pain are positively associated with pain-related disability, 
pain intensity, and chronic pain behavior. Similarly negative states associated with dental care-
related fear include avoidance of dental treatment and poorer oral, systemic, and psychological 
health, among others, as discussed above. Fear of pain appears to be a critical component of 
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dental care-related fear (e.g., McNeil & Berryman, 1989), though also is important in its own 
right (i.e., in understanding the pain experience across numerous populations and pain 
conditions). Improving our understanding of fear of pain and fears about dental treatment, both 
separately and as related constructs, may inform interventions aimed at reducing the burden of 
these phenomena. 
 Though much is known about the etiology of both general fear of pain and dental care-
related fear, there is a dearth of literature addressing the role of genetics. A single study has 
estimated the heritability of fear of pain, with no other known work on the impact of genetic 
factors on the development and maintenance of the phenotype. In the dental care-related fear 
literature, only four known studies have sought to elucidate the role of genes in predisposing 
individuals to clinically significant levels of fear. Nevertheless, biological and genetic variables 
likely are etiologically important for both fear of pain and dental care-related fear (McNeil & 
Randall, 2014). Studies that assess the role of genetics in these phenomena are necessary in order 
for their conceptualizations to be more comprehensive and complete. An understanding of fear of 
pain and dental care-related fear that includes genetic variables has the potential to shape 
personalized interventions that are most efficacious (i.e., personalized medicine and dentistry). 
 The central goal of the current study was to expand upon the limited genetic knowledge 
related to fear of pain and dental care-related fear. With regard to the comprehensive conceptual 
model describing dental care-related fear proposed by McNeil and Randall (2014) and 
acknowledged earlier, the current study was designed to provide evidence for associations 
between the components of the model highlighted in Figure 1. Given the theoretically important 
and previously identified association between dental care-related fear and the MC1R gene, the 
first aim of the study was to determine whether MC1R gene variant status predicts dental care-
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related fear, with the expectation of replicating the findings of the Binkely et al. (2009) study. 
The second aim of the study was to, for the first time, determine whether MC1R gene variant 
status predicts general fear of pain. The third aim of the study was to examine whether fear of 
pain mediates the association between MC1R gene variant status and dental care-related fear. 
Finally, as a secondary objective, the study explored whether other candidate genes are related to 
fear of pain and dental care-related fear. The ultimate goal of this project was to contribute to 
two bodies of literature – fear of pain and dental care-related fear – such that conceptualizations 
of these public health problems may be refined in ways that can influence the development and 
implementation of the treatments that target them. 
Hypotheses 
 First, drawing on previous research (Binkley et al., 2009), it was hypothesized that MC1R 
gene variant status would predict level of dental care-related fear in a large Appalachian 
community sample of adults (Hypothesis 1). Second, given the relation previously observed 
between MC1R gene variant status and fear of dental pain (Binkely et al., 2009), and the well-
replicated finding that dental care-related fear and general fear of pain are associated (e.g., 
McNeil & Berryman, 1989), it was expected that MC1R variant status would predict level of 
general fear of pain in the same sample (Hypothesis 2). Third, and conditional on results 
supporting Hypotheses 2 and 3, it was anticipated that the relation between MC1R gene variant 
status and dental care-related fear would be mediated by fear of pain (Hypothesis 3). 
Method 
Design 
 The current investigation utilized existing data from a large, family-based study of the 
Center for Oral Health Research in Appalachia, cohort 1 (COHRA1), the same data set from 
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which the previously reported heritability estimates for fear of pain and dental care-related fear 
were calculated (Randall et al., 2016b). The larger, cross-sectional project was initiated to 
identify in an Appalachian sample determinants of oral diseases at the community-, family-, and 
individual levels, and data were collected over a seven-year period. A comprehensive protocol 
included a large battery of self-report measures related to several aspects of oral health 
(including psychosocial ones), standardized interviews, oral health assessment, microbiological 
assessment, and DNA collection. The study protocol was developed by a committee with 
expertise in genetics, microbiology, epidemiology, biostatistics, behavioral science, community 
assessment, rural health, and dentistry (Polk et al., 2008). A complete description of the study 
protocol is beyond the scope of this manuscript; it has been described elsewhere (see Marazita et 
al., 2005; Polk et al., 2008). Methods of self-report data collection for this study have been 
outlined and critiqued (see Randall, McNeil, Crout et al., 2013). Written informed consent was 
obtained from adult participants and parents or legal guardians of child participants; verbal 
assent was obtained from children who could grant assent. The study design and all materials 
were approved by the Institutional Review Boards of West Virginia University and the 
University of Pittsburgh. 
Participants 
 Participants were recruited in Webster and Nicholas counties of West Virginia and 
Allegheny, Washington, and McKean counties of Pennsylvania. According to the household-
based protocol, eligibility criteria required that households must contain at least one biological 
parent-child (i.e., age 1 to 18 years) pair. All members of eligible households who volunteered 
were invited to participate, without regard to biological or legal relationships and without regard 
to oral health status. Psychosis, neurological impairment, and severe physical or mental disability 
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comprised participant exclusion criteria. Households were excluded if at least one member of the 
biological parent-offspring pair exhibited impaired blood clotting or diminished capacity to resist 
infection. Given the recruitment strategy, a community-based sample that reflects a range of the 
Appalachian population was obtained – a notable range in socioeconomic statuses, cultural 
behaviors, attitudes, and access to oral health care was observed (Polk et al., 2008). Additionally, 
racial and ethnic composition of this part of the Appalachian region was reflected in the sample 
(Polk et al., 2008). On the whole, participants in this sample, as compared to the greater USA 
population, were socioeconomically disadvantaged and suffered from poorer oral health across 
several indices (e.g., Martin et al., 2008; Shaffer et al., 2012; Wang et al., 2010). 
In total, 732 households were enrolled in the COHRA1 study, with 2,663 individuals 
participating from 740 biological families. For the proposed project, only genotyped participants 
who completed measures of fear of pain and dental care-related fear were included in analyses 
(participants age 11 years and older completed such measures). To ensure participant 
independence, only those who were not genetically related were included in the sample (e.g., 
included only one member [mother] of a biological mother-child pair); the result was the 
inclusion of only adults, as children were enrolled in the COHRA1 study as a function of 
relatedness to at least one enrolled parent and, for the current study, parents were selected for 
over children in the elimination of genetically related participants. Furthermore, in keeping with 
human MC1R studies (e.g., Binkely et al., 2009, Liem et al., 2005), and to allow for 
straightforward comparison, only self-reported Caucasian/white participants were included in 
final analyses.2 Thus, the current study involved the analysis of data for 817 participants. Figure 
2 depicts the selection of these participants from the full COHRA1 sample.  
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Self-Report Assessment Instruments 
 Demographic questionnaire. A questionnaire designed to collect demographic 
information was developed specifically for the purposes of the COHRA1 study, and variables 
included are outlined elsewhere (Polk et al., 2008). For the current study, reported age (years), 
sex, education (years), and socioeconomic status (measured by a validated proxy, the 
“community ladder” item of the MacArthur Scale of Subjective Social Status; Adler & Stewart, 
2007; See Appendix B) were the demographic variables utilized. 
 Fear of Pain Questionnaire-9. The Fear of Pain Questionnaire-9 is a self-report measure 
of fears about pain, generally (FPQ-9; McNeil et al., 2017). The 9-item instrument contains three 
factor analytically derived subscales: Fear of Severe Pain, Fear of Minor Pain, and Fear of 
Medical/Dental Pain. Responses are made using a 5-point Likert-type scale; an indication of how 
fearful the respondent is of the pain associated with each of several painful experiences is 
provided. The FPQ-9 assesses fears about pain induced by a broad range of stimuli or situations. 
The instrument is presented in Appendix C. Each subscale contains three items and possible 
scores range from 3-15; possible total score ranges from 9-45. Higher scores are indicative of 
greater levels of fear of pain. 
    The FPQ-9 was developed from the longer Fear of Pain Questionnaire-III (FPQ-III; 
McNeil & Rainwater, 1998). The FPQ-III has established norms for clinical (i.e., chronic pain 
patients, general medical outpatients) and nonclinical populations, and well-evidenced reliability 
and validity (McNeil & Rainwater, 1998; Osman, Breitenstein, Barrios, Gutierrez, & Kopper, 
2002; Roelofs et al., 2005). The FPQ-9 retains the factor structure of the FPQ-III (Randall, 
Waddell et al., 2013) and has similarly strong reliability and validity as the FPQ-III (McNeil et 
al., 2017). It has been used with success in several studies (e.g., Randall et al. 2012). For its 
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strong psychometric properties and utility, and its ability to tap general fear of pain, this 
instrument is of value for the current study. 
 Dental Fear Survey. The Dental Fear Survey (DFS) is a 20-item, self-report measure of 
fearful and anxious reactions to dental stimuli and situations (Kleinknecht, Klepac, & Alexander, 
1973; see Appendix D). The instrument assesses both physiological and behavioral responses to 
dental situations (e.g., increased heart rate during dental treatment, avoidance of treatment via 
appointment cancellation). Additionally, the instrument assesses severity of the fear response to 
various dental stimuli (e.g., the dental chair, the anesthetic needle, the sound of the drill). Using a 
5-point Likert-type scale, respondents rate how much each physiological or behavioral response 
occurs or how much fear/anxiety they experience when presented with fear-inducing dental 
stimuli. Total sore ranges from 20-100; higher scores indicate greater levels of dental care-
related fear. Three factor analytically derived subscales comprise the DFS: one related to 
anticipatory anxiety and treatment avoidance, one related to fear of specific stimuli, and the other 
related to physiological arousal associated with dental treatment/stimuli (Kleinknecht et al., 
1973). 
 The DFS is very widely used in behavioral dentistry research because of its strong 
psychometric properties. Stability in the factors and scores across time has been observed in both 
clinical and nonclinical samples (Kleinknecht et al., 1973) and internal consistency and test-
retest reliability has been confirmed (Kleinknecht, Thorndike, McGlynn, & Harkavy, 1984; 
McGlynn, McNeil, Gallagher, & Vrana, 1987). Predictive, convergent, and discriminant validity 
also has been observed (Smith & Moore, 1994; Wilson & Sinisko, 1997). A critical review of 
anxiety and pain measures in dentistry resulted in the suggestion that the DFS be used to measure 
dental care-related fear in research applications involving adults (Newton & Buck, 2000). Given 
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its psychometric properties and comprehensiveness, the DFS is preferable in research settings to 
other measures of dental care-related fear (Newton & Buck, 2000), such as Corah’s Dental 
Anxiety Scale (used in the Binkely et al. [2009] study), and as such is utilized in the current 
study. It should be noted, however, that the DFS, while important historically and currently, has 
been criticized for not being based on theory. For instance, the DFS utilizes a single summary 
score without a clear rationale and may be more appropriate for clinical practice than for 
research (Armfield, 2010b). While other and more recent dental care-related fear self-report 
assessments exist (e.g., Armfield, 2010b), the DFS has been used extensively (Armfield, 2010a) 
and continues to have utility, particularly in comparing results in longitudinal investigations and 
cross-sectionally in comparison to prior studies. Participants of the COHRA1 study completed 
the DFS and FPQ-9 as part of the larger battery of study questionnaires. 
DNA Collection and Available Genetic Data 
 During the early part of the COHRA1 study, DNA was collected for all consenting 
participants from blood samples procured by trained phlebotomists from peripheral veins (Polk 
et al., 2008). The majority of COHRA1 study participants, however provided saliva or cheek 
swab samples from which DNA was extracted (Polk et al., 2008). The change in DNA collection 
method resulted from the availability of improved methodologies, allowing reliable extraction 
from saliva. Collected DNA was genotyped on an Illumina platform (600,000 SNPs). The 
genotype data already have been extensively validated, cleaned, quality checked, and formatted 
for statistical analysis (see Data Cleaning Report; Marazita, 2010). 
 Though the MC1R gene was not explicitly sequenced for each COHRA1 study 
participant, 31 SNPs within the MC1R coding region had been genotyped or imputed, and those 
data were available for the study sample. Each of these SNPs were considered for use in analyses 
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for the present study, though only 6 ultimately, were utilized. In determining MC1R gene variant 
status in a similar study, Binkely and colleagues (2009) determined the genotype of each 
participant at 12 SNPs, and sequenced the entire coding region of the gene for approximately 
half of their sample. In the end, the authors of that study utilized only eight SNPs to determine 
MC1R variant status, based on results of a study indicating the MC1R SNPs that most likely 
significantly decrease the function of the gene (Binkely et al., 2009; García-Borrón, Sánchez-
Laorden, & Jiménez-Cervantes, 2005). To be congruent with the Binkely et al. (2009) study on 
the relation between MC1R gene variants and dental care-related fear, this study involved 
labeling as variant minor allele(s) the same SNP(s). The data available for this project included 
six of the SNPs targeted by Binkely and colleagues (2009), and notably the MC1R SNP most 
well-known for being related to pain sensitivity and/or decreased anesthetic efficacy (i.e., 
rs1805007). The following SNPs were analyzed for the present study: rs1805006, rs11547464, 
rs1805007, rs1110400, rs1805008, rs1805009 (labeled using protein product notation in the 
Binkley et al. [2009] study: D84E, R142H, R151C, I155T, R160W, and D294H, respectively). 
These SNPs were chosen not only for comparability to the study by Binkley and colleagues 
(2009), but, like in that study, also based on their likelihood of affecting MC1R function. Minor 
alleles at these six SNPs are missense (coding) variants responsible for amino acid residue 
changes that are predicted to be deleterious to protein function (García-Borrón et al., 2005). The 
SNPs are moderate (<10%) to low (<1%) frequency coding variants and linkage disequilibrium 
among them is low (r2 < 0.2; see Table 1). 
Determining MC1R Variant Status 
 For the proposed project, genetic data were combined across SNPs to calculate a risk 
score, as was done by Binkely and colleagues (2009). Variant (i.e., minor) alleles were 
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determined by referencing SNPedia (http://www.snpedia.com) and GeneCards 
(http://www.genecards.org) and are reported with study results as consistent with similar 
literature (e.g., MacQueen et al., 2014). Participants were assigned to one of two groups based on 
the number of SNPs for which they carry a minor allele: zero target SNPs, or one or more target 
SNPs. Variant status thus describes whether MC1R variations are present. Participants with 
minor allele(s) at one or more target SNPs were considered to have positive variant status, and 
participants with no variation at these SNPs were considered to have negative variant status. 
With regard to determination of MC1R variant status, study results do not differ based on method 
of MC1R variant group assignment. For example, very similar (and not statistically different) 
results are obtained when participants are sorted into the following three groups: participants 
with zero variant alleles, participants with one variant allele, and participants with two (or more) 
variant alleles. 
Determining MC4R, OPRM1, COMT, and SCN9A Variant Status 
As noted earlier, the MC4R gene is potentially functionally related to the MC1R gene, 
though the two are on different chromosomes (i.e., MC4R is on chromosome 18). A common 
MC4R SNP (Chowdhury et al., 2013) was selected to be used in analyses for the present study: 
rs11872992. Presence of the minor allele was labeled as variant for the study. OPRM1 variation 
has been associated with pain perception; rs 1799971 (i.e., A118G) is the OPRM1 SNP that has 
been linked to experimentally-induced pain sensitivity (Fillingim et al., 2005), and for which 
presence of the minor allele was labeled as variant for these study analyses. With regard to 
COMT, participants with the minor allele at one or both of two SNPs (rs6269 and rs4818) were 
labeled as variant. These SNPs are highly predictive of the role of COMT in temporomandibular 
joint disorder (TMD; Diatchenko et al., 2005). Lastly, and similarly, participants with the minor 
 29 
allele at one or both of two SNPs (rs6746030 and 41268673) on SCN9A, which have been 
associated with pain disorders (e.g., Reimann et al., 2010), were labeled as variant. 
Statistical Analyses 
 Following determination of MC1R variant status for all participants, demographic, fear of 
pain, and dental care-related fear data were merged with genetic data, and quality of the data 
merging process was checked. Missing data for demographic variables were accounted for using 
regression imputation; 1 participant was missing age data, 10 participants were missing 
education data, and 21 participants were missing subjective social status data. The same process 
was utilized to account for missing FPQ-9 and DFS data, as outlined by Randall and colleagues 
(2013). There were no missing genetic data for the study sample. As is recommended in the 
literature (Tabachnick & Fidell, 2007), univariate outliers were screened for by considering 
standardized scores; none were found. All statistical analyses were performed using SPSS 
Statistics 21 (IBM SPSS, Chicago, IL) and the PROCESS macro (Hayes, 2013) for SPSS 
Statistics. Effect size calculations (i.e., Cohen’s d) for t-tests were conducted using Effect Size 
Calculators (Becker, 1999). 
Results 
Sample Characteristics, Fear of Pain, and Dental Care-Related Fear 
First, descriptive statistics (e.g., means and standard deviations) were calculated, and 
bivariate correlational analyses were employed to determine the relation between fear of pain, 
dental care-related fear, age, education, and socioeconomic status for the total sample. The 
sample of 817 participants comprised 511 females (62.5%), and mean age was 34.7 years (SD = 
8.7, range = 18-67). Participants had, on average, 13.1 years of education (SD = 2.5, range = 4-
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23). The average response on the “community ladder” item of the MacArthur Scale of Subjective 
Social Status was 5.7 (SD = 2.0, range = 1-10). 
Mean FPQ-9 score was 23.2 (SD = 8.1. range = 9-45) and mean DFS score was 39.2 (SD 
= 19.2, range = 20-100). Mean subscale scores for both measures are listed in Table 2. Average 
FPQ-9 and DFS scores were consistent with those observed in studies of similar populations 
(e.g., Randall et al., 2012). As has been previously reported for this sample (Randall et al., 
2016b), distributions of FPQ-9 and DFS matched existing research: negatively skewed, with 
nearly 15% of participants reporting extremely high levels of fear of pain and/or phobic levels of 
dental care-related fear. Bivariate correlations between demographic variables and FPQ-9 and 
DFS scores are listed in Table 3. 
Basic between-group comparisons (i.e., t-tests) were utilized to determine whether there 
are differences in general fear of pain and dental care-related fear between males and females for 
the total sample. Females reported higher (FPQ-9 M = 24.6, SD = 7.9) and males reported lower 
(FPQ-9 M = 21.2, SD = 7.8) levels of fear of pain, t(815) = 5.9, p < 0.001, Cohen’s d = .41. 
Likewise, females reported higher (DFS M = 40.3, SD = 19.6) and males reported lower (DFS M 
= 37.5, SD = 18.2) levels of dental care-related fear, t(815) = 2.0, p = .04, Cohen’s d = .14. This 
sex difference, of small effect size, has been widely observed, specifically in dental care-related 
fear, and across many fears (see Craske, 2003; McNeil & Randall, 2014). Demographic data and 
FPQ-9 and DFS subscale data, divided by sex, are reported in Table 4. Age and subjective social 
status were not significantly associated with FPQ-9 or DFS scores; education was not 
significantly associated with FPQ-9 score and was significantly, but only weakly, associated with 
DFS score (see Table 3). In light of these findings, sex, but not other demographic variables, was 
controlled for in subsequent analyses. 
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MC1R Variation 
In total, 546 participants had no MC1R risk variants, 249 had one risk variant, and 22 had 
two risk variants; no participant had more than two variants. Thus, 271 participants (33.2%) had 
at least one risk allele, a proportion consistent with that observed in the dark-haired Caucasian 
(i.e., not redhead) subsample of the only other similar study (Binkely et al. 2009). Table 5 
summarizes the proportion of the sample with MC1R risk alleles for each of the study SNPs, and 
notes minor allele for each of the SNPs. 
Basic between-group comparisons (i.e., chi-square, t-tests) were utilized to determine 
whether there were sex, age, education, or socioeconomic differences between positive and 
negative MC1R variant status. Given that there exist potential sex differences in the heritability 
of dental care-related fear (Ray et al., 2010) and that the influence of MC1R on pain perception 
may be sex-specific (Delaney et al., 2010), it was imperative to test the effect of sex on MC1R 
variant status. In this sample, females and males did not differ in their likelihood of having one 
or more MC1R risk alleles, X2 (2, N = 817) = 1.86, p = .17 (160 of 511 females and 110 of 306 
males in the sample had one or more MC1R variant). Similarly, presence of risk alleles at one or 
more MC1R SNPs was not associated with age, t(815) = 1.4, p = .15, education, t(815) = .25, p = 
.80, nor subjective social status, t(815) = 1.23, p = .22. 
MC1R Variation, Fear of Pain, and Dental Care-Related Fear 
To address Hypotheses 1 and 2, that MC1R gene variant status predicts dental care-
related fear and fear of pain, respectively, multiple linear regression analyses were utilized. An 
additive hierarchical regression was conducted with MC1R gene variant status as the independent 
variable and either dental care-related fear or fear of pain as the dependent variable, controlling 
for covariates (i.e., sex). There were no issues with muticollinearity. 
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MC1R variant status was predictive of dental care-related fear, F(2,814) = 4.20, p = .02, 
R2 = .01, controlling for sex. Likewise, MC1R variant status was predictive of general fear of 
pain, F(2,814) = 21.08, p < .001, R2 = .05, controlling for sex. Presence of one or more MC1R 
variant(s) was associated with increased DFS and FPQ-9 scores. See Table 6 for results of 
regression analyses. 
The MC1R variant status scoring scheme used in this study (i.e., calculating a risk score 
by determining whether participants had variation at either none or one or more of six SNPs, as 
in Binkely et al. [2009]) may mask the reporting of individual SNPs and the association among 
genetic variation and phenotype. Thus, the association of variation at each of the study SNPs 
with DFS and FPQ-9 scores was investigated independently by SNP. Those results are presented 
in Table 7. For only one SNP, rs1805007, presence of the minor allele significantly predicted 
DFS and FPQ-9 scores. The other SNPs were not significantly related to either dental care-
related fear nor fear of pain and showed large standard errors of their effect estimates, indicating 
insufficient power to precisely model their effects. Additionally, variation at four of the six SNPs 
is relatively rare in this sample. As such, study results appear to be driven predominantly by 
variation at rs1805007. 
To address Hypothesis 3, that fear of pain mediates the relation between MC1R variant 
status and dental care-related fear, mediation was tested using the PROCESS macro (Hayes, 
2013) for SPSS Statistics. Relative indirect effects were subjected to post hoc bootstrap analyses 
with 5000 samples and a 95-percentile confidence interval estimate. PROCESS allows for 
dichotomous independent variables in mediational analyses as well as analysis of data that are 
not normally distributed (as in the case of the DFS and FPQ-9 data in the current study), and is 
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the contemporary strategy of choice for determining mediation effects in research with 
psychological phenomena. 
FPQ-9 and DFS scores were moderately correlated (r = .50, p < .001). Given, this 
association, and the well-supported suggestion that fear of pain is a primary component of dental 
care-related fear (McNeil & Berryman 1989), a single mediator model was tested with fear of 
pain (FPQ-9 score) as the mediating variable to explain the association between MC1R variant 
status and dental care-related fear (DFS score); see Table 8 and Figure 3. Full mediation was 
observed. There was a significant indirect effect of MC1R variant status on dental care-related 
fear through fear of pain, B = 1.60, BCa CI [0.281, 3.051]. The size of this effect was small to 
moderate, ĸ2 = .044, 95% BCa CI [.009, .082]. 
Exploratory Analyses 
 To complete the secondary and exploratory objective of this study, the same general 
statistical approach as was used for the MC1R data was used to determine whether variants of the 
MC4R, OPRM1, COMT and SCN9A genes were associated with fear of pain and/or dental care-
related fear, given the literature summarized earlier. 
 MC4R. Of 817 participants, 207 (25.3%) had risk a risk allele at the MC4R SNP 
genotyped for this study (rs11872992). MC4R variation was not associated with MC1R variation, 
X2 (2, N = 817) = .86, p = .36. Controlling for sex, MC4R variation was predictive of lower DFS 
score (for participants with the MC4R risk allele, DFS M = 36.8, SD = 18.4; for participants 
without MC4R risk allele, DFS M = 40.1, SD = 19.4), F(2,814) = 4.04, p = .02, R2 = .01. Results 
of the regression model used to test this association are presented in Table 9. There was no 
difference in FPQ-9 score between participants with and without MC4R variation, t(815) = 1.8, p 
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= .07. Given that there was no significant relation between MC4R variant status and fear of pain, 
follow-up mediational analysis was not warranted. 
 OPRM1, COMT, and SCN9A. In this sample, 181 (22.2%) participants had the risk 
allele for the OPRM1 SNP analyzed. Variance on the OPRM1 gene was associated with neither 
FPQ-9 score, t(815) = .06, p = .96, nor DFS score, t(815) = .78, p = .43. The prevalence of 
participants with risk allele(s) at one or both of the COMT SNPs analyzed for this study was 
62.2% (n = 508). COMT variance was not associated with FPQ-9 score, t(815) = .62, p = .54, nor 
DFS score, t(815) = .41, p = .68. Approximately one-third (31.7%; n = 259) of the participants 
had risk allele(s) at one or both of the SCN9A SNPs analyzed for the study. SCN9A variance had 
no association with FPQ-9 score, t(815) = .45, p = .65, nor DFS score, t(815) = .26, p = .80. 
Discussion 
As expected, MC1R variant status is associated with dental care-related fear. Participants 
with one or more risk alleles in the MC1R coding region were more likely than those with none 
to report greater levels of dental care-related fear on the DFS, supporting Hypothesis 1. MC1R 
variant status also is associated with general fear of pain. In support of Hypothesis 2, participants 
with one or more variants in the MC1R coding region were more likely than those with none to 
report greater levels of fear of pain, as measured by the FPQ-9. Perhaps most fascinating – and 
important – is the finding that the relation between MC1R variant status and DFS score is 
explained by FPQ-9 score. That is, fear of pain fully mediates the relation between MC1R variant 
status and dental care-related fear, providing support for Hypothesis 3. Interestingly, variation at 
one study SNP, rs1805007, appears to drive these observed associations. 
 Critically, these findings extend those of the few other studies on the topic of genetic 
contributions to dental care-related fear. As mentioned earlier, three studies have demonstrated 
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moderate to high heritability for dental care-related fear (30-47%; Randall et al., 2016b; Ray et 
al., 2010; Vassend et al., 2011). And, as highlighted previously, Binkely and colleagues (2009) 
determined that MC1R variant status (i.e., having one or more gene variants versus no variants) 
predicts greater fear of dental pain and dental care-related fear, as well as a two-fold increase in 
the likelihood of avoiding dental care. Results of the current study provide the first known 
confirmation of the primary findings reported by Binkley and others (2009), replicating the result 
of the only other known study on the topic. Taken together, it is clear that the experience of 
dental care-related fear is influenced by genetic factors. Moreover, the MC1R gene appears to be 
linked to dental care-related fear, and may be especially important in the development and 
maintenance of dental care-related fear for some people. 
If the literature on the etiology of dental care-related fear is scant with data informing our 
understanding of genetic contributions, then the same can be said about the fear of pain 
literature. Notably, only one study has addressed the heritability of general fear of pain, 
demonstrating a moderate degree (i.e., 34%) in a community sample of adolescents and adults, 
the same sample from which the current data are drawn (Randall et al., 2016b). Only two other 
studies provide evidence for potential genetic contributions to the experience of fear of pain. 
First, the same study that demonstrated a link between MC1R variation and dental care-related 
fear (Binkley et al., 2009) also showed that MC1R risk alleles are predictive of fear of dental 
pain, a distinct from, though partially overlapping, general fear of pain (van Wijk, McNeil, Ho, 
Buchanan, & Hoogstraten, 2006). Second, the 5-hydroxytryptamine (serotonin) receptor 3B gene 
(HTR3B) has been associated with pain catastrophizing, a phenomenon that overlaps partially 
with fear of pain (Horjales-Araujo et al., 2013). There is a budding literature on how genetic 
variation may play a role in the development and manifestation of fear of pain, and this study 
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contributes to that literature. The present study offers evidence that there are genetic influences 
in the experience of fear of pain, and is the first to implicate MC1R variation as a contributor to 
general fear of pain. 
Building on existing work summarized here, this study demonstrates that the association 
between MC1R risk alleles and dental care-related fear is through an association between MC1R 
variation and fear of pain, and is the first to do so. By extension, this finding offers preliminary 
biological support for the well-documented notion that fear of pain is a primary component of 
dental care-related fear (McNeil & Berryman, 1989). Equally or perhaps even more interesting, 
results of the current study suggest that the role of genetic factors in the development and 
maintenance of dental care-related fear may be through pain-related phenomena. That fear of 
pain is the mediating variable in the association between MC1R variant status and dental care-
related fear suggests that genetically-influenced differences in pain experience (e.g., pain 
threshold, tolerance) are potential cause for fear of pain, which may then underpin dental care-
related fear. 
As observed in a number of studies, MC1R variation is associated with heightened 
sensitivity to pain, including dental pain specifically (e.g., Delaney et al., 2010; Liem et al., 
2005; Mogil et al., 2005). The experience of acute and chronic pain can trigger and/or exacerbate 
fear of pain, which in turn can influence pain perception and pain behavior. For instance, those 
who have experienced acute and/or chronic orofacial pain are more likely than those who have 
not to later report fear of pain (van Wijk & Hoogstraten 2005). And, those with higher levels of 
fear of pain are more likely to perceive pain stimuli as more intense (van Wijk & Hoogstraten 
2009), to engage in pain catastrophizing (Parr et al. 2012), and to engage in avoidance behaviors 
that worsen the pain experience (Lee et al. 2007). Of course, and as was replicated in the current 
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study, fear of pain is moderately to strongly correlated with dental care-related fear, which is 
predictive of dental treatment avoidance (e.g., Armfield et al., 2007; Doerr et al., 1998). 
Conceivably, then, MC1R risk alleles may predispose some people to be more sensitive to pain 
than others, leading them to have more negative (i.e., painful) experiences with dental treatment. 
This, in turn, may make those individuals more likely to develop fears about pain and associated 
fears about dental treatment, and, ultimately, to avoid dental treatment with greater frequency. 
Comment on Results of Exploratory Analyses 
Given existing literature, it was expected that variation in genes in addition to MC1R 
would be associated with fear of pain and/or dental care-related fear, and so it was surprising that 
none of the exploratory analyses afforded meaningfully significant results. For the exploratory 
analyses, MC4R was chosen as a candidate gene because of its known association with anxiety 
behavior (Chaki & Okuyama, 2005). Similarly, OPRM1, COMT, and SCN9A were chosen as 
candidate genes for exploratory analyses for their known associations, generally, with pain 
sensitivity and pain perception (e.g., Andersen & Skorpen, 2009; Drenth & Waxman, 2009; 
Fillingim et al., 2005). COMT, for example, has even been implicated as important in influencing 
the orofacial pain experience, as COMT variation is associated with chronic TMD (e.g., Smith et 
al., 2011). 
MC4R was the only candidate gene associated with dental care-related fear, and neither 
MC4R nor the other candidate genes included in the exploratory analyses were associated with 
fear of pain. It is difficult to offer conjecture on these negative results. However, it may be the 
case that variation in these genes is not associated with dental pain sensitivity, and that the 
genetic influence on dental pain sensitivity, specifically, is important in any relation between 
gene variation and dental care-related fear. Though the SNPs analyzed for each of these genes 
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were chosen for their documented associations with pain sensitivity and/or other pain-related 
phenomena, it also may be the case that other SNPs on these candidate genes would have served 
as better markers of relations between genes and fear of pain and/or dental care-related fear, 
should such relations exist. Lastly, it may be the case that the study sample was not large and/or 
diverse enough to detect associations between the candidate genes and fear of pain and/or dental 
care-related fear. Future work on influence of genetic factors on dental pain, fear of pain, and 
dental care-related fear should include these genes in order to further establish their role (or non-
role) in those phenotypes. 
Implications of the Study 
Generally, the results of this study strengthen the conceptualization of dental care-related 
fear in that they confirm an etiological role of genetics. Moreover, the results provide additional 
evidence for a pain-related genetic contribution to the etiology of dental care-related fear. 
Importantly, the critical roles of pain and fear of pain are underscored by the study findings. 
Dental care-related fear, with fear of pain as its primary component, most certainly impacts the 
orofacial pain experience, and is impacted by the orofacial pain experience. The bidirectional 
influence of orofacial pain on dental care-related fear is well documented, as described above. In 
worst case scenarios, patients can become caught in a “vicious cycle” of dental care-related fear. 
In such cases, patients have a painful dental experience, subsequently develop dental care-related 
fear as a result of aversive conditioning, then avoid necessary dental treatment due to fear, only 
to have the fear perpetuated when they finally must seek dental treatment that inevitably is 
especially painful due to neglect (and would otherwise not have been painful if they had not 
engaged in fear-related avoidance; see Armfield et al., 2007). If patients are genetically 
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predisposed to be hypersensitive to orofacial pain (perhaps through MC1R gene variation), it 
follows that they are more likely to end up in such a cycle. 
In addition to operating through pain-related mechanisms, there may be a small but 
potentially important involvement of genetics in dental care-related fear through influence on 
other important psychological variables. For example, genetic variability may influence basic 
learning (e.g., conditioning, sensitization, desensitization) in ways that promotes or buffers 
development/maintenance of dental care-related fear. Because the systemic, oral, and 
psychological health burdens of dental care-related fear are so profound, a complete 
conceptualization of the phenomenon is essential. Drawing on the results of this study, future 
research in the areas of fear of pain and dental care-related fear should incorporate genetic 
variables, including MC1R, whenever possible, in order to elucidate their most comprehensive 
conceptualizations. 
From a clinical standpoint, and at the most basic level, results from this study suggest that 
targeting fear of pain may promote successful amelioration of dental care-related fear. In 
addition, attending to the idiographic pain experiences of patients may be useful in the treatment 
of fear of pain and/or dental care-related fear. This study demonstrates promise in the utilization 
of biomarkers to inform dental treatment planning. Given study results, it may be that knowledge 
of a patient’s MC1R status could allow his/her dental care provider to tailor treatment so as 
buffer the patient from increased risk of fear of pain and dental care-related fear, a la 
personalized medicine/dentistry. For the practicing dental professional, for example and 
hypothetically, this may take the form of screening patients for MC1R variation early in life, and 
adapting dental treatment protocol to ensure that those with variants receive particularly 
comfortable care to reduce their likelihood of experiencing aversive or traumatic dental treatment 
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and, ultimately, to reduce their likelihood of developing fear of pain and/or dental care-related 
fear. Such a recommendation is, of course, premature at this point. Additional research is 
necessary to uncover the mechanisms by which MC1R variation is related to fear of pain and the 
critical biological pathways involved. Additional research also is necessary to determine the 
most efficacious ways to utilize knowledge of MC1R variant status to inform clinical practice, 
both for the dental clinician, who may be concerned with pain and fear management, and the 
mental health clinician, who may be concerned with the treatment of already-developed fears 
about pain and/or dentistry. 
Limitations 
Study limitations include, first, that as a function of utilizing archival data from a larger 
project aimed at addressing oral health in Appalachia, the sample is geographically and culturally 
restricted and results may not be generalizable. Replication with samples from other areas is 
necessary. Moreover, this study and the only other one suggesting a link between MC1R and 
dental care-related fear, analyzed data for only Caucasian/white participants. To more thoroughly 
and accurately understand the role of MC1R variation in the experience of dental care-related 
fear, and to simultaneously offer a more nuanced understanding of that association and improve 
generalizability, the same analyses must be completed with members of other ethnic/racial 
groups. Additionally, self-reported ethnicity/race was used to select cases for study analyses and 
so may not match genetic ancestry. Future studies should verify participant ethnicity using 
genotype data and, for samples that include multiple ethnicities, analyses should be stratified by 
ethnicity/race or adjusted for using principal components of ancestry. 
A second limitation of this study is the reliance of self-report instruments to measure the 
phenotypes of interest. While the questionnaires utilized are psychometrically strong, multimodal 
 41 
and behavioral assessment of fear of pain and dental care-related fear would strengthen future 
study design. Third, no measure of dental treatment-seeking behavior (e.g., time since last dental 
visit) was utilized. Dental care-related fear certainly is an important phenotype in its own right; 
however, whether a patient’s dental treatment–seeking behavior is reduced due to fear is 
ultimately most important. Those data were not available for the current study, but should be 
included in future work on the topic. It also may be helpful to include as a study variable (and 
control for) history of dental trauma, including previous experiences of particularly painful 
dental treatment. Such data, and no good proxy for such a variable, was available for the current 
sample. Lastly, available data are cross sectional, which limits conclusions that can be drawn 
from mediational analyses. Longitudinal data may allow for stronger claims to be made about the 
causal relations between genetic variation, fear of pain, dental care-related fear, and dental 
treatment-seeking behavior. 
Directions for Future Research 
Future research should utilize experimental measures of the orofacial pain experience 
(e.g., quantitative sensory testing) to determine how MC1R and other gene variants are related 
specifically to orofacial pain perception and to clarify whether orofacial pain sensitivity bridges 
the path between MC1R variant status and fear of pain (and associated dental care-related fear). 
Given the results of the current study, and those that demonstrate that MC1R may be important 
for sensitivity to pain, such an exploration is warranted. Follow-up studies also should test 
whether MC1R variation is related to orofacial pain sensitivity, specifically, or general pain 
sensitivity (and, similarly, whether MC1R variation is related to dental care-related fear, 
specifically, or fear of medical and other healthcare procedures, broadly). Moreover, there should 
be studies that address how MC1R SNPs affect protein expression and function, and associated 
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downstream effects, so that the mechanism(s) by which gene variation is associated with fear of 
pain and dental care-related fear can be elucidated. Studies that expand understanding of the 
specific role(s) of genes like MC1R may provide additional avenues by which to target pain 
hypersensitivity and fear of pain that can contribute to dental care-related fear. Gene-by-
environment studies of the influence of genetics on pain perception, fear of pain, and/or dental 
care-related fear also may be warranted, particularly given the theoretical understanding of the 
relations between these constructs and their impact on dental treatment-seeking patterns as 
posited by McNeil and Randall (2014). 
The regression models presented here, linking MC1R variation, fear of pain, and dental 
care-related fear, account for only a small proportion of the variance in fear of pain and dental 
care-related fear (i.e., 1-5%). As noted earlier, heritability of fear of pain and dental care-related 
fear is moderate to high (Randall et al., 2016b). Thus, it is likely that there are genes in addition 
to MC1R that may influence fear of pain and dental care-related fear through involvement in pain 
and/or anxiety pathways or by other means. Future work in the area of genetic influences on fear 
of pain and dental care-related fear should include genes other than those that were the focus of 
this study so as to provide an even more comprehensive picture. 
Summary  
To conclude, this study corroborates previous work suggesting that MC1R variants are 
associated with dental care-related fear. The study is the first to show that MC1R variant status 
predicts general fear of pain. And, most importantly, results presented here indicate that fear of 
pain plays a mediational role in the association between MC1R variant status and dental care-
related fear. Critically, it is clear that genetic variation contributes to the etiology of dental care-
related fear. This study demonstrates promise in the potential further identification of biomarkers 
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that may be useful in determining and personalizing dental treatment. Moreover, these results 
have important implications for how we understand psychosocial correlates of orofacial pain and 
dental treatment-seeking behavior, and provide possible specific targets for the treatment of 
orofacial pain, fear of pain, and/or dental care-related fear. 
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Footnotes 
1     ‘Dental care-related fear and anxiety’ represents the most precise terminology to describe the 
phenomena that may be experienced in the context of dental and dental-related stimuli that are 
perceived to be threatening. As described in more detail below, dental care-related fear and 
dental care-related anxiety are related but distinct constructs that can occur independently of one 
another and/or concurrently (i.e., “mixed”) in individuals (McNeil, Vargovich, Turk, & Ries, 
2012). Indeed, limited research on the etiology, assessment, and treatment of dental care-related 
fear and anxiety has attempted to disentangle the two, and the phenomena often are confused for 
one another, treated as the same, and/or considered in tandem. See McNeil & Randall (2014) for 
a comprehensive commentary on this issue. For simplicity, the term ‘dental care-related fear’ is 
used throughout.   
2     Of note, Caucasian/white participants (i.e., those included in the current study sample and for 
whom data were analyzed) were not statistically different from their non-Caucasian/white 
counterparts in the full COHRA1 sample on the proportion of females to males, age, years of 
education, socioeconomic status (i.e., the “community ladder item of the MacArthur Scale of 
Subjective Social Status, described below), nor level of dental care-related fear (i.e., Dental Fear 
Survey score, described below). However, Caucasian/white participants had, on average, lower 
levels of fear of pain (i.e., Fear of Pain Questionnaire-9 score, described below) than did their 
non-Caucasian/white counterparts (M = 23.3, SD = 8.1 for Caucasian/white participants, M = 
25.7, SD = 9.3 for non-Caucasian/white participants), t(897) = 2.54, p = .01. As expected, 
likelihood of having one or more MC1R variant (method of genotyping and determining of 
variant status described below) was greater for Caucasian/white participants than for non-
Caucasian/white participants, X2 (1, N = 911) = 14.70, p < .001 (271 of 817 Caucasian/white 
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participants and 13 of 94 non-Caucasian/white participants in the full COHRA1 sample had one 
or more MC1R variant). Likewise, likelihood of having the MC4R variant was greater for 
Caucasian/white participants than for non-Caucasian/white participants, X2 (1, N = 911) = 5.00, p 
= .025 (207 of 817 Caucasian/white participants and 14 of 94 non-Caucasian/white participants 
in the full COHRA1 sample had the MC4R variant). The same trend was observed for OPRM1, 
X2 (1, N = 911) = 6.75, p = .009 (181 of 817 Caucasian/white participants and 10 of 94 non-
Caucasian/white participants in the full COHRA1 sample had the OPRM1 variant), and for 
SCN9A, X2 (1, N = 911) = 6.28, p = .012 (259 of 817 Caucasian/white participants and 18 of 94 
non-Caucasian/white participants in the full COHRA1 sample had one or more SCN9A variant). 
Caucasian/white and non-Caucasian/white participants in the full COHRA1 sample did not differ 
significantly in their likelihood of having one of more COMT variant. The relatively large 
difference in size of the Caucasian/white and non-Caucasian/white subsamples is acknowledged 
as a limitation.        
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Table 1 
Linkage Disequilibrium (r2) Among Genotyped MC1R SNPs 
 rs11547464 rs1805006 rs1805007 rs1805008 rs1805009 
rs1110400 .00008 .02 .0004 .002 .0001 
rs11547464  .00005 .0009 .0009 .00002 
rs1805006   .0004 .003 .00006 
rs1805007    .003 .0004 
rs1805008     .0009 
 
  
 68 
Table 2 
Mean FPQ-9 and DFS Total and Subscale Scores 
 
M SD Range 
Total FPQ-9 23.2 8.1 9-45 
     Minor Pain 
     Subscale 6.0 2.4 3-15 
     Severe Pain  
     Subscale 9.8 3.7 3-15 
     Medical Pain  
     Subscale 7.6 3.3 3-15 
Total DFS 39.2 19.2 20-100 
     Avoidance  
     Subscale 13.2 7.4 8-40 
     Fear of Specific      
     Stimuli Subscale 14.8 7.5 6-30 
     Physiological  
     Arousal Subscale 9.2 4.8 5-25 
 
Note. N = 817. 
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Table 3 
Bivariate Correlations between Demographic Variables, FPQ-9 Score, and DFS Score 
 
Education Subjective Social Status 
Total FPQ-9 
Score 
Total DFS 
Score 
Age .15*** .16*** .06 .02 
Education  .19*** -.03 -.11** 
Subjective 
Social Status   -.003 -.05 
Total FPQ-9 
Score    .50*** 
 
Note. Correlation statistic = Pearson correlation coefficient (r). **p < .01. ***p < .001.  
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Table 4 
Demographic, FPQ-9, and DFS Data by Participant Sex  
 Females  Males 
 M SD Range  M SD Range 
Age (years) 33.6 8.1 18-66 
 
36.7 9.4 20-67 
Education (years) 13.1 2.3 7-22 
 
12.8 2.7 4-23 
Subjective Social 
Status 5.7 2.0 1-10 
 
5.8 2.0 1-10 
Total FPQ-9 24.6 7.9 9-45 
 
21.2 7.8 9-45 
     Minor Pain 
     Subscale 6.2 2.4 3-15 
 
5.6 2.4 3-15 
     Severe Pain  
     Subscale 10.4 3.7 3-15 
 
8.8 3.6 3-15 
     Medical Pain  
     Subscale 8.1 3.3 3-15 
 
6.7 3.1 3-15 
Total DFS 40.3 19.6 20-100 
 
37.5 18.2 20-100 
     Avoidance  
     Subscale 13.4 7.7 8-40 
 
12.8 7.0 8-40 
     Fear of Specific      
     Stimuli Subscale 15.3 7.5 6-30 
 
13.9 7.2 6-30 
     Physiological  
     Arousal Subscale 9.4 5.0 5-25 
 
8.8 4.4 5-25 
 
Note. N = 817. Females n = 511. Males n = 306. 
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Table 5 
Proportion of Study Sample with Risk Alleles across Genotyped MC1R SNPs 
SNP (minor allele) n % of sample 
rs1805008 (T) 132 16.2 
rs1805007 (T) 126 15.4 
rs1110400 (C) 18 2.2 
rs1805006 (A) 10 1.2 
rs1805009 (C) 4 .5 
rs11547464 (A) 3 .4 
 
Note. N = 817. 
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Table 6 
Regression Models for MC1R Variant Status Predicting Dental Care-Related Fear and Fear of 
Pain 
 DFS Total Score 
 
FPQ-9 Total Score 
Predictor Variable B SE β p 
 
B SE β p 
Sex 2.93 1.38 .07 .03 
 
3.45 .57 .21 < .001 
MC1R Variant Status 2.94 1.41 .07 .04 
 
1.53 .59 .09 .009 
 
Note. B: Unstandardized regression coefficient. SE: Standard Error. β: Standardized regression 
coefficient.  
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Table 7 
Independent Regression Models for Prediction of Dental Care-Related Fear and Fear of Pain by 
Genotyped MC1R SNPs 
 DFS Total Score  FPQ-9 Total Score 
Predictor Variable B SE β p  B SE β p 
Sex 2.80 1.38 .07 .04  3.38 .98 .20 < .001 
rs1805008 .35 1.82 .007 .85  .68 .75 .03 .36 
Sex 3.10 1.38 .08 .03  3.50 .57 .21 < .001 
rs1805007 5.94 1.85 .11 .001  2.37 .76 .11 .002 
Sex 2.80 1.38 .07 .04  3.38 .97 .20 < .001 
rs1110400 2.24 4.56 .02 .62  -.17 1.88 -.003 .93 
Sex 2.75 1.40 .07 .05  3.38 .57 .20 < .001 
rs1805006 -7.88 6.08 -.05 .20  .28 2.52 .004 .91 
Sex 2.84 1.38 .07 .04  3.39 .57 .20 < .001 
rs1805009 -14.6 9.58 -1.52 .13  -6.24 3.96 -.06 .112 
Sex 2.79 1.38 .07 .04  3.38 .57 .20 < .001 
rs11547464 9.03 11.06 .03 .42  5.87 4.60 .04 .20 
 
Note. B: Unstandardized regression coefficient. SE: Standard Error. β: Standardized regression 
coefficient. Predictor variables labeled as MC1R SNPs (by rs number) refer to presence of minor 
allele at indicated SNP. For the one SNP (rs1805007) for which presence of minor allele 
significantly predicted dental care-related fear and fear of pain, bolded above, model statistics 
are: F(2,814) = 7.23, p = .001, R2 = .02 (dental care-related fear [DFS Score]); F(2,814) = 22.58, 
p < .001, R2 = .05 (fear of pain [FPQ-9 Score]). Threshold for statistical significance was set at p 
= .008 after Bonferroni correction for multiple tests.  
 74 
Table 8 
Mediation Model: Fear of Pain as Mediator between MC1R Variant Status and Dental Care-
Related Fear 
 B SE t p CI (lower) CI (upper) 
X → M (a) 1.36 .60 2.28 .023* .1917 2.5369 
M → Y (b) 1.17 .07 16.17 < .001** 1.0306 1.3153 
X → Y (c) 2.80 1.42 1.97 .049* .0112 5.5895 
X → Y (c’) 1.20 1.24 .97 .334 -1.2356 3.6358 
X → M → Y 1.60 .71   .2812 3.0506 
 
Note. X = MC1R variant status; M = FPQ-9 score (mediator); Y = DFS score;  
B = Unstandardized regression coefficient; SE = Standard error; * p < .05; ** p < .001. 
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Table 9 
Regression Model for MC4R Variant Status Predicting Dental Care-Related Fear 
 DFS Total Score 
 
Predictor Variable B SE β p 
 
Sex 2.60 1.38 .07 .06 
 
MC4R Variant Status -3.06 1.54 -.07 .04 
 
 
Note. B: Unstandardized regression coefficient. SE: Standard Error. β: Standardized regression 
coefficient.  
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Figure 1. Study variables and their theoretical connections, drawn from a comprehensive 
conceptual model describing dental care-related fear. Adapted from: McNeil, D. W., & Randall, 
C. L. (2014). Dental fear and anxiety associated with oral health care: Conceptual and clinical 
issues. In D. Mostofsky & A. Fortune (Eds.), Behavioral dentistry (2nd ed., pp. 165-192). Ames, 
IA: John Wiley & Sons, Inc. (See Appendix A). 
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Figure 2. Selection of participants for study analyses. COHRA1 = Center for Oral Health 
Research in Appalachia family-based study on determinants of oral disease, cohort 1. DFS = 
Dental Fear Survey. FPQ-9 = Fear of Pain Questionnaire-9.   
Excluded: Participants who are 
first-degree relatives of other 
participants in the sample (e.g., 
children or parents of probands) 
(n = 389) 
Genetically independent COHRA1 
participants with available genetic, 
DFS, and FQ-9 data 
(n = 911) 
Excluded: Non-Caucasian 
participants 
(n = 94) 
 
§ Black / African American (n = 64) 
§ Hispanic (n = 8) 
§ Asian (n = 4) 
§ Native American / Alaska Native (n = 2) 
§ Other (n = 5) 
§ Not reported (n = 11) 
Participants included in study 
analyses 
(n = 817) 
All COHRA1 participants with 
available genetic, DFS, and FPQ-9 
data 
(n = 1,300) 
All COHRA1 participants  
(n = 2,663) 
Excluded: Participants who did not 
complete DFS and FPQ-9  
(i.e., those age < 11 years) 
 (n = 1,363) 
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Figure 3. Fear of pain explains association between MC1R variant status and dental care-related  
 
fear. X = MC1R variant status; Y = Dental Care-Related Fear (DFS Score); B = Unstandardized  
 
regression coefficient; * p < .05; ** p < .001. 
  
 
Fear of Pain 
 
MC1R Variant Status Dental Care-Related Fear 
B = 1.36, p = .023* B = 1.17, p < .001** 
Direct effect: X → Y (c), B = 2.80, p = .049* 
Direct effect: X → Y (c’), B = 1.20, p = .334 
Indirect effect, B = 1.60, 95% CI [.2813, 3.0506]* 
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Appendix A 
Conceptual Model of Dental Treatment-Seeking Patterns 
 
 
 
Reprinted from: McNeil, D. W., & Randall, C. L. (2014). Dental fear and anxiety associated with 
oral health care: Conceptual and clinical issues. In D. Mostofsky & A. Fortune (Eds.), 
Behavioral dentistry (2nd ed., pp. 165-192). Ames, IA: John Wiley & Sons, Inc. 
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Appendix B 
The MacArthur Scale of Subjective Social Status, Community Ladder Item 
 
 
 
Reprinted from: Adler, N., & Stewart, J. (2007). The MacArthur Scale of Subjective Social 
Status. Retrieved from: http://www.macses.ucsf.edu/research/psychosocial/subjective.php 
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Appendix C 
Fear of Pain Questionnaire – 9  
 
 
INSTRUCTIONS: The items listed below describe painful experiences. Please look at each 
item and think about how FEARFUL you are of experiencing the PAIN associated with each 
item. If you have never experienced the PAIN of a particular item, please answer on the basis of 
how FEARFUL you expect you would be if you had such an experience. Circle one number for 
each item below to rate your FEAR OF PAIN in relation to each event. 
 
I FEAR the PAIN associated with: 
 
                                           Not At All  A Little  A Fair 
Amount  
Very Much  Extreme  
 
 
1.  Breaking your arm.  1  2  3  4  5  
 
2.  Having a foot doctor 
remove a wart from 
your foot with a sharp 
instrument.  
 
1  2  3  4  5  
3.  Getting a paper-cut on 
your finger.  
 
1  2  3  4  5  
4.  Receiving an injection 
in your mouth.  
 
1  2  3  4  5  
5.  Getting strong soap in 
both your eyes while 
bathing or showering.  
 
1  2  3  4  5  
6.  Having someone slam a 
heavy car door on your 
hand.  
 
1  2  3  4  5  
7.  Gulping a hot drink 
before it has cooled.  
 
1  2  3  4  5  
8.  Receiving an injection 
in your hip/buttocks.  
 
1  2  3  4  5  
9.  Falling down a flight of 
concrete stairs. 
1  2  3  4  5 
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Appendix D 
Dental Fear Survey 
 
 
INSTRUCTIONS: The items in this questionnaire refer to various situations, feelings, and 
reactions related to dental work. Please rate your feeling or reaction on these items by using the 
following scales. Fill in the appropriate circle which most closely corresponds to your reaction. 
 
 
 
 Never Once or 
twice 
A few 
times 
Often Nearly 
every time 
 
1. Has fear of dental work ever caused you 
    to put off making an appointment? 
 
○ ○ ○ ○ ○ 
2. Has fear of dental work ever caused you 
__to cancel or not appear for an 
__appointment? 
○ ○ ○ ○ ○ 
 
 
When having dental work done: 
 
 Not At 
All 
A 
little 
Somewhat Much Very 
much 
 
3. My muscles become tense… 
 
○ ○ ○ ○ ○ 
4. My breathing rate increases… 
 
○ ○ ○ ○ ○ 
5. I perspire… 
 
○ ○ ○ ○ ○ 
6. I feel nauseated and sick to my stomach… 
 
○ ○ ○ ○ ○ 
7. My heart beats faster… ○ ○ ○ ○ ○ 
 
 
 
 
CONTINUED ON NEXT PAGE 
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Following is a list of things, and situations that many people mention as being somewhat anxiety 
or fear producing. Please rate how much fear, anxiety, or unpleasantness each of them causes 
you. (If it helps, try to imagine yourself in each of these situations and describe what your 
common reaction is.) 
 
 Not At 
All 
A 
little 
Somewhat Much Very 
much 
 
8. Making an appointment for dentistry. 
 
○ ○ ○ ○ ○ 
9. Approaching the dentist’s office. 
 
○ ○ ○ ○ ○ 
10. Sitting in the waiting room. 
 
○ ○ ○ ○ ○ 
11. Being seated in the dental chair. 
 
○ ○ ○ ○ ○ 
12. The smell of the dentist’s office. 
 
○ ○ ○ ○ ○ 
13. Seeing the dentist walk in. 
 
○ ○ ○ ○ ○ 
14. Seeing the anesthetic needle. 
 
○ ○ ○ ○ ○ 
15. Feeling the needle injected. 
 
○ ○ ○ ○ ○ 
16. Seeing the drill. 
 
○ ○ ○ ○ ○ 
17. Hearing the drill. 
 
○ ○ ○ ○ ○ 
18. Feeling the vibrations of the drill. 
 
○ ○ ○ ○ ○ 
19. Having your teeth cleaned. 
 
○ ○ ○ ○ ○ 
20. All things considered, how fearful are you 
___of having dental work done? 
○ ○ ○ ○ ○ 
 
 
